Mark L. Baum

Founder and CEO
Board member

Mr. Baum is a founder, board member and CEO of Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY). Beginning in 2011, Mr. Baum led the restructuring and reorganization of Imprimis,

read more »

Andrew R. Boll

Chief Financial Officer

Mr. Boll has been the Chief Financial Officer of Imprimis Pharmaceuticals since February 2015. Mr. Boll oversees our accounting and financial reporting, investor relations, human resources and other operational departments.

read more »

John Saharek

Chief Commercial Officer

Mr. Saharek is a senior healthcare industry executive with over 30 years of broad experience developing and commercializing pharmaceutical, biotech, surgical device and diagnostic product portfolios.

read more »

Gary Seelhorst

Vice-President, Business Development

Mr. Seelhorst, has over 17 years of clinical and corporate development experience with both large-cap pharmaceutical companies (e.g. Eli Lilly and Pfizer) as well as start-up ventures including extensive capital raising, licensing, and M&A transactions.

read more »

Joe Bitterman

Senior Operations Director

Mr. Bitterman is an experienced pharmacy operations leader with a 30-year track record of acquiring, building and maintain high performing pharmacies. Mr. Bitterman joins us most recently from UCSD Health Systems where he was the Pharmacy Manager of Perlman Medical Center.

read more »

Victor Repkin

Intellectual Property Analyst

Victor Repkin, Ph.D., has served as patent attorney and intellectual property analyst for Imprimis Pharmaceuticals since June 2013.  Dr. Repkin has more than 15 years of experience in patent preparation and prosecution, patent counseling and due diligence.

read more »